ZA864561B - Expression of human il-2 in mammalian cells by a recombinant poxvirus - Google Patents

Expression of human il-2 in mammalian cells by a recombinant poxvirus

Info

Publication number
ZA864561B
ZA864561B ZA864561A ZA864561A ZA864561B ZA 864561 B ZA864561 B ZA 864561B ZA 864561 A ZA864561 A ZA 864561A ZA 864561 A ZA864561 A ZA 864561A ZA 864561 B ZA864561 B ZA 864561B
Authority
ZA
South Africa
Prior art keywords
expression
human
mammalian cells
recombinant poxvirus
poxvirus
Prior art date
Application number
ZA864561A
Inventor
Marie-Paule Kieny
Paul Sondermeyer
Jean-Pierre Lecocq
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of ZA864561B publication Critical patent/ZA864561B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA864561A 1985-06-21 1986-06-19 Expression of human il-2 in mammalian cells by a recombinant poxvirus ZA864561B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8509480A FR2583770B1 (en) 1985-06-21 1985-06-21 EXPRESSION OF HUMAN IL-2 IN MAMMALIAN CELLS BY A RECOMBINANT POXVIRUS

Publications (1)

Publication Number Publication Date
ZA864561B true ZA864561B (en) 1987-03-25

Family

ID=9320527

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA864561A ZA864561B (en) 1985-06-21 1986-06-19 Expression of human il-2 in mammalian cells by a recombinant poxvirus

Country Status (7)

Country Link
EP (1) EP0206939A1 (en)
JP (1) JPS63500005A (en)
AU (1) AU5967686A (en)
DK (1) DK87887D0 (en)
FR (1) FR2583770B1 (en)
WO (1) WO1986007610A1 (en)
ZA (1) ZA864561B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells
CA1339346C (en) * 1986-08-01 1997-08-26 Ian Allister Ramshaw Recombinant chimeric vaccine
US7238673B2 (en) 1989-03-31 2007-07-03 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
JPH02148451U (en) * 1989-05-18 1990-12-17
JPH02148450U (en) * 1989-05-18 1990-12-17
JPH02148452U (en) * 1989-05-18 1990-12-17
US5834441A (en) * 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
US6652850B1 (en) 1993-09-13 2003-11-25 Aventis Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
FR2710536B1 (en) * 1993-09-29 1995-12-22 Transgene Sa Anti-cancer use of a viral vector comprising a gene which modulates the immune and / or inflammatory response.
US6344445B1 (en) 1995-10-19 2002-02-05 Cantab Pharmaceutical Research Limited Herpes virus vectors and their uses
FR2766091A1 (en) 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION
JP4634710B2 (en) * 2002-07-31 2011-02-16 ゲネルクス コーポレーション Microorganisms and cells for tumor diagnosis and treatment
WO2013083254A1 (en) 2011-12-09 2013-06-13 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
WO1984002077A1 (en) * 1982-11-30 1984-06-07 Us Health Process for producing poxvirus recombinants for expression of foreign genes

Also Published As

Publication number Publication date
DK87887A (en) 1987-02-20
FR2583770B1 (en) 1988-08-19
AU5967686A (en) 1987-01-13
JPS63500005A (en) 1988-01-07
FR2583770A1 (en) 1986-12-26
EP0206939A1 (en) 1986-12-30
WO1986007610A1 (en) 1986-12-31
DK87887D0 (en) 1987-02-20

Similar Documents

Publication Publication Date Title
ZA852563B (en) A novel human physiologically active polypeptide
ZA868629B (en) Skin moisturizing microemulsions
EP0210461A3 (en) Physiologically active polypeptide buf-3
AU561081B2 (en) Human cultured cell line and colony-stimulating factor produced therein
ZA864561B (en) Expression of human il-2 in mammalian cells by a recombinant poxvirus
GB2181349B (en) Skin care composition
ZA872768B (en) Enhanced expression of human interleukin-2 in mammalian cells
AU580797B2 (en) Improvements in relation to cyclosporin therapy
NZ225983A (en) Use of eukaryotic cells to produce recombinant interleukin-2
GB8715489D0 (en) Skin care compositions
ZA868748B (en) Mammalian interleukin-4
EP0335900A4 (en) Human interleukin-4 muteins
EP0197525A3 (en) Plant culture cell and use thereof
PT79810A (en) Expression of human alpha-1-antitrysin in yeast
GB2177607B (en) Improvements in and relating to cues
GB8602994D0 (en) Skin care composition
GB8531925D0 (en) Propagation of yeast
AU582574B2 (en) The preparation of polypeptides having human gamma interferon activity
AU598737B2 (en) Improvements relating to chairs
GB8826453D0 (en) Use of lak cells
AU8695791A (en) Expression of biologically active pdgf analogs in eucaryotic cells
GB8511822D0 (en) Control of pistons in direct drive
IE851202L (en) Cloned human interleukin 1
IE820313L (en) Expression of polypeptides in yeast
YU117785A (en) Bionic ornitopter for human flying with own power